Myeloproliferative disorders and its associated mutations

سال انتشار: 1393
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 51

فایل این مقاله در 9 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_REMJ-2-4_002

تاریخ نمایه سازی: 22 دی 1402

چکیده مقاله:

Myeloproliferative Neoplasm (MPN) are a clonal disorder in hematopoietic stem cells (HSC). MPN is categorized to ۸ subclasses, including chronic myeloid leukemia (CML), polycythemia vera (PV), essential thrombocytopenia (ET), primary myelofibrosis (PMF), systematic mastositosis (SM), chronic eosinophilic leukemia (CEL), chronic neutrophilic leukemia (CNL), and unclassified myelofibrosis disorders (UMPN). It usually occurs in ۵th to ۷th decade of life. However, CNL and ET have been observed in children. A lot of mutations have been identified in these disorders that Jak۲V۶۱۷F is the most important mutation. Moreover, several somatic mutations other than JAK۲V۶۱۷F in MPN patients have been reported. Such mutations include MPL, TET۲, ASXL۱, IDH۱, IDH۲, CBL, LNK, IKZF, and EZH۲ from precursor stem cells. The role of mutations mentioned is not clear in pathogenesis of this disease. Hence, in this study, mutations in different stages of myeloproliferative disorders have been reviewed.

کلیدواژه ها:

نویسندگان

Kaveh Tari

Department of Hematology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran

Reza Yarahmadi

Department of Laboratory Sciences, School of Paramedical Sciences, Ahvaz Jundishapur University of Medical sciences, Ahvaz, Iran

Amir Tabatabaei

Department of Laboratory Sciences, School of Paramedical Sciences, Ahvaz Jundishapur University of Medical sciences, Ahvaz, Iran

Fakhredin Saba

Department of Hematology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran

Saeid Abroun

Department of Hematology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran

Amir Atashi

Department of Hematology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran

Masoud Soleimani

Department of Hematology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Santos FP, Verstovsek S. JAK۲ inhibitors: What's the true therapeutic ...
  • Mesa RA, Silverstein MN, Jacobsen SJ, Wollan PC, Tefferi A. ...
  • Mithraprabhu S, Grigoriadis G, Khong T, Spencer A. Deactylase inhibition ...
  • Jemal A, Siegel R, Ward E, Murray T, Xu J, ...
  • Mascarenhas J, Mughal T, Verstovsek S. Biology and clinical management ...
  • Tefferi A, Vardiman J. Classification and diagnosis of myeloproliferative neoplasms: ...
  • Tefferi A, Thiele J, Vardiman JW. The ۲۰۰۸ World Health ...
  • Vainchenker W, Dusa A, Constantinescu SN, editors. JAKs in pathology: ...
  • Verstovsek S, Manshouri T, Quintás-Cardama A, Harris D, Cortes J, ...
  • Firmbach-Kraft I, Byers M, Shows T, Dalla-Favera R, Krolewski J. ...
  • Kiss R, Polgár T, Kirabo A, Sayyah J, Figueroa NC, ...
  • Luo H, Hanratty W, Dearolf C. An amino acid substitution ...
  • Sayyah J, Sayeski PP. Jak۲ inhibitors: rationale and role as ...
  • Saharinen P, Vihinen M, Silvennoinen O. Autoinhibition of Jak۲ tyrosine ...
  • Baffert F, Régnier CH, De Pover A, Pissot-Soldermann C, Tavares ...
  • Darnell JE. STATs and gene regulation. Science. ۱۹۹۷;۲۷۷(۵۳۳۲):۱۶۳۰-۵ ...
  • Schaefer TS, Sanders LK, Nathans D. Cooperative transcriptional activity of ...
  • Cacalano NA, Migone TS, Bazan F, Hanson EP, Chen M, ...
  • Leonard WJ, O'Shea JJ. Jaks and STATs: biological implications*. Annual ...
  • O'Shea JJ. Jaks, STATs, cytokine signal transduction, and immunoregulation: are ...
  • Jatiani SS, Baker SJ, Silverman LR, Reddy EP. JAK/STAT pathways ...
  • Walter MJ, Ding L, Shen D, Shao J, Grillot M, ...
  • Kirabo A, Park SO, Majumder A, Gali M, Reinhard MK, ...
  • Levine RL, Wadleigh M, Cools J, Ebert BL, Wernig G, ...
  • Shannon K, Van Etten RA. JAKing up hematopoietic proliferation. Cancer ...
  • Delhommeau F, Jeziorowska D, Marzac C, Casadevall N. Molecular aspects ...
  • Tefferi A. Novel mutations and their functional and clinical relevance ...
  • Passamonti F, Maffioli M, Caramazza D, Cazzola M. Myeloproliferative neoplasms: ...
  • Levine RL, Pardanani A, Tefferi A, Gilliland DG. Role of ...
  • Malinge S, Ben-Abdelali R, Settegrana C, Radford-Weiss I, Debre M, ...
  • Toyama K, Karasawa M, Yokohama A, Mitsui T, Uchiumi H, ...
  • Baxter EJ, Scott LM, Campbell PJ, East C, Fourouclas N, ...
  • Kralovics R, Passamonti F, Buser AS, Teo S-S, Tiedt R, ...
  • Lacronique V, Boureux A, Della Valle V, Poirel H, Quang ...
  • Cuesta-Domínguez Á, Ortega M, Ormazábal C, Santos-Roncero M, Galán-Díez M, ...
  • Reiter A, Walz C, Watmore A, Schoch C, Blau I, ...
  • Adelaide J, Perot C, Gelsi-Boyer V, Pautas C, Murati A, ...
  • Bousquet M, Quelen C, De Mas V, Duchayne E, Roquefeuil ...
  • Skoda R. The genetic basis of myeloproliferative disorders. ASH Education ...
  • Jekarl DW, Han SB, Kim M, Lim J, Oh E-J, ...
  • Lane SW, Fairbairn DJ, McCarthy C, Nandini A, Perry‐Keene J, ...
  • Poitras JL, Cin PD, Aster JC, DeAngelo DJ, Morton CC. ...
  • Nebral K, Denk D, Attarbaschi A, König M, Mann G, ...
  • Van Roosbroeck K, Cox L, Tousseyn T, Lahortiga I, Gielen ...
  • Olcaydu D, Kralovics R. The role of janus kinases in ...
  • Kralovics R, Passamonti F, Buser AS, Teo S-S, Tiedt R, ...
  • Shi L, Wang S, Zangari M, Xu H, Cao TM, ...
  • Chen E, Beer PA, Godfrey AL, Ortmann CA, Li J, ...
  • Scott LM, Tong W, Levine RL, Scott MA, Beer PA, ...
  • Martínez-Avilés L, Besses C, Álvarez-Larrán A, Cervantes F, Hernández-Boluda JC, ...
  • Pardanani A, Lasho T, Finke C, Hanson C, Tefferi A. ...
  • Pikman Y, Lee BH, Mercher T, McDowell E, Ebert BL, ...
  • Pikman Y, Lee BH, Mercher T, McDowell E, Ebert BL, ...
  • Pardanani AD, Levine RL, Lasho T, Pikman Y, Mesa RA, ...
  • Tefferi A, Pardanani A, Lim K, Abdel-Wahab O, Lasho T, ...
  • Tefferi A, Lim K, Abdel-Wahab O, Lasho T, Patel J, ...
  • Schaub FX, Looser R, Li S, Hao-Shen H, Lehmann T, ...
  • Jankowska AM, Szpurka H, Tiu RV, Makishima H, Afable M, ...
  • Tong W, Zhang J, Lodish HF. Lnk inhibits erythropoiesis and ...
  • Tong W, Zhang J, Lodish HF. Lnk inhibits erythropoiesis and ...
  • Simon C, Chagraoui J, Krosl J, Gendron P, Wilhelm B, ...
  • Tanaka S, Miyagi S, Sashida G, Chiba T, Yuan J, ...
  • Reynolds R, Browning G, Nawroz I, Campbell I. Von Recklinghausen's ...
  • Green A, Beer P. Somatic mutations of IDH۱ and IDH۲ ...
  • Pardanani A, Lasho T, Finke C, Mai M, McClure R, ...
  • Gelsi‐Boyer V, Trouplin V, Roquain J, Adélaïde J, Carbuccia N, ...
  • Abdel-Wahab O, Pardanani A, Patel J, Wadleigh M, Lasho T, ...
  • Mascarenhas J, Roper N, Chaurasia P, Hoffman R. Epigenetic abnormalities ...
  • Grand FH, Hidalgo-Curtis CE, Ernst T, Zoi K, Zoi C, ...
  • Loh ML, Sakai DS, Flotho C, Kang M, Fliegauf M, ...
  • Jäger R, Gisslinger H, Passamonti F, Rumi E, Berg T, ...
  • Jäger R. ۴۳۵ Deletions of the Transcription Factor Ikaros in ...
  • Patriarca A, Colaizzo D, Tiscia G, Spadano R, Di Zacomo ...
  • Olcaydu D, Rumi E, Harutyunyan A, Passamonti F, Pietra D, ...
  • Coco FL, Pisegna S, Diverio D. The AML۱ gene: a ...
  • Cammenga J, Niebuhr B, Horn S, Bergholz U, Putz G, ...
  • Osato M, Asou N, Abdalla E, Hoshino K, Yamasaki H, ...
  • Szymañska K, Hainaut P. TP۵۳ and mutations in human cancer. ...
  • Harutyunyan A, Klampfl T, Cazzola M, Kralovics R. p۵۳ lesions ...
  • Oren M, Rotter V. Mutant p۵۳ gain-of-function in cancer. Cold ...
  • Chen I-M, Harvey RC, Mullighan CG, Gastier-Foster J, Wharton W, ...
  • Mullighan CG, Su X, Zhang J, Radtke I, Phillips LA, ...
  • نمایش کامل مراجع